Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1-1

derived from them. Cluster was based on the 914 genes reporting at least 4-fold difference in expression ratios between original tumor 0_A1 vs original tumor 0_B1. Cell lines were stained with specific fluorescently-conjugated mAb to Cytokeratin 18, Platelet-derived growth factor receptor (Pdgfr) α or β, as indicated, in parallel with appropriate isotype control-matched mAb and analyzed by flow cytometry. In the histograms shown, the thick black line represents positive staining and the gray filled lines represent the isotype control-matched staining. The percent of positive cells after compensation is shown on the upper right of each panel.<p><b>Copyright information:</b></p><p>Taken from "Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1"</p><p>http://www.molecular-cancer.com/content/7/1/29</p><p>Molecular Cancer 2008;7():29-29.</p><p>Published online 7 Apr 2008</p><p>PMCID:PMC2329667.</p><p>